Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Clinical Lymphoma, Myeloma & Leukemia
|
September 12, 2020
Bortezomib, Lenalidomide, and Dexamethasone in Elderly Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Claude Chahine, Damien Roos-Weil, Véronique Saada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 12, 2017
Challenges and perspectives in the immunotherapy of Hodgkin lymphoma
Jean-Marie Michot, Julien Lazarovici, David Ghez, et al.
BMJ Case Reports
|
August 11, 2011
Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?
Marie-Olivia Chandesris, David Ghez, Caroline Besson, et al.
Clinical Lymphoma & Myeloma
|
April 28, 2006
Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma
David Ghez, Diane Damotte, Susan P Perrine, et al.
Journal of Clinical Microbiology
|
November 12, 2010
Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin
Felipe Suarez, Gaelle Olivier, Dea Garcia-Hermoso, et al.
Haematologica
|
June 8, 2019
Ibrutinib induces multiple functional defects in the neutrophil response against <i>Aspergillus fumigatus</i>
Damien Blez, Marion Blaize, Carole Soussain, et al.
Transplantation
|
November 10, 2009
Rapamycin for refractory acute graft-versus-host disease
David Ghez, Marie Thérèse Rubio, Natacha Maillard, et al.
Annals of Hematology
|
July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia
Edouard Cornet, Alain Delmer, Pierre Feugier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience
Elie Rassy, Alina Danu, Toni Ibrahim, et al.
Haematologica
|
January 2, 2016
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
David Sibon, Franck Morschhauser, Matthieu Resche-Rigon, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Clinical Lymphoma, Myeloma & Leukemia
|
September 12, 2020
Bortezomib, Lenalidomide, and Dexamethasone in Elderly Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Claude Chahine, Damien Roos-Weil, Véronique Saada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 12, 2017
Challenges and perspectives in the immunotherapy of Hodgkin lymphoma
Jean-Marie Michot, Julien Lazarovici, David Ghez, et al.
BMJ Case Reports
|
August 11, 2011
Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?
Marie-Olivia Chandesris, David Ghez, Caroline Besson, et al.
Clinical Lymphoma & Myeloma
|
April 28, 2006
Fas ligand-mediated lethal hepatitis after rapid lysis of a localized natural killer cell lymphoma
David Ghez, Diane Damotte, Susan P Perrine, et al.
Journal of Clinical Microbiology
|
November 12, 2010
Breakthrough Hormographiella aspergillata infections arising in neutropenic patients treated empirically with caspofungin
Felipe Suarez, Gaelle Olivier, Dea Garcia-Hermoso, et al.
Haematologica
|
June 8, 2019
Ibrutinib induces multiple functional defects in the neutrophil response against <i>Aspergillus fumigatus</i>
Damien Blez, Marion Blaize, Carole Soussain, et al.
Transplantation
|
November 10, 2009
Rapamycin for refractory acute graft-versus-host disease
David Ghez, Marie Thérèse Rubio, Natacha Maillard, et al.
Annals of Hematology
|
July 5, 2014
Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia
Edouard Cornet, Alain Delmer, Pierre Feugier, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 5, 2020
Outcomes of Transplant-Eligible Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Salvage Chemotherapy: The Gustave Roussy Experience
Elie Rassy, Alina Danu, Toni Ibrahim, et al.
Haematologica
|
January 2, 2016
Single or tandem autologous stem-cell transplantation for first-relapsed or refractory Hodgkin lymphoma: 10-year follow-up of the prospective H96 trial by the LYSA/SFGM-TC study group
David Sibon, Franck Morschhauser, Matthieu Resche-Rigon, et al.
Page
of 8